miRoncol Health
miRoncol leadership

Christopher M. Gallagher, MD

Co-Founder & Chief Medical Officer

Chris brings the clinical perspective that turns an analytical signal into a responsible medical pathway. He keeps the company focused on how screening information will be interpreted, investigated and used in real care.

20+ YEARSMEDICAL ONCOLOGYCLINICAL RESEARCH
Christopher M. Gallagher, MD
Experience behind the platform

Why Chris’s experience matters.

Christopher M. Gallagher, MD, is a practicing medical oncologist with more than 20 years of experience in cancer treatment and clinical research. A graduate of Georgetown University School of Medicine, he has held leadership roles across breast-cancer research and cancer services within the MedStar Health system.

His experience includes leadership in major clinical-trial programs and physician-directed cancer care. At miRoncol, he guides clinical strategy, study design and the boundary between a screening signal and diagnosis.

That distinction is central to miRoncol’s development philosophy. A relevant signal should create a reason for further clinical investigation, while diagnosis and treatment remain with the appropriate medical team.

“NGS preserves the possibilities. PCR provides the focus. Longitudinal data creates the history.”

Related company milestones.

Appointment as Chief Medical Officer

Ontario Health Study collaboration

One multidisciplinary company

Five leadership perspectives. One platform direction.

Company building, clinical oncology, diagnostic translation, bioinformatics and marketing work together to move miRoncol from research to responsible applications.

Explore miRoncol